Literature DB >> 21752979

Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease.

Karen Miernyk1, Julie Morris, Dana Bruden, Brian McMahon, Debby Hurlburt, Frank Sacco, Alan Parkinson, Thomas Hennessy, Michael Bruce.   

Abstract

Helicobacter pylori infection is common in Alaska. The development of severe H. pylori disease is partially determined by the virulence of the infecting strain. Here we present vacA and cagA genotype data for H. pylori strains isolated from Alaskans and their correlation with clinical disease. We enrolled patients scheduled for esophagogastroduodenoscopy and positive for H. pylori infection. Gastric biopsy specimens from the stomach antrum and fundus were cultured. We performed PCR analysis of the H. pylori vacA gene and for the presence of the cagA gene and cagA empty site. We genotyped 515 H. pylori samples from 220 Native and 66 non-Native Alaskans. We detected the cagA gene in 242/286 (85%) persons; of 222 strains that could be subtyped, 95% (212) were non-Asian cagA and 3% (6) were East Asian cagA. After removing mixed infections (n = 17), 83% of H. pylori strains had either the vacA s1m1 (120/269) or s2m2 (103/269) genotype. Sixty-six percent (68/103) of H. pylori strains with the vacA s2m2 genotype also contained the cagA gene. Infection with an H. pylori strain having the cagA gene or vacA s1m1 genotype (compared with s1m2 and s2m2) was associated with a decreased risk of esophagitis (P = 0.003 and 0.0003, respectively). Infection with an H. pylori strain having the vacA s1m1 genotype (compared with s1m2 and s2m2) was associated with an increased risk of peptic ulcer disease (PUD) (P = 0.003). The majority of H. pylori strains in this study carried the non-Asian cagA gene and either the vacA s1m1 or s2m2 genotype. A majority of H. pylori strains with the vacA s2m2 genotype also contained the cagA gene. There was an association of H. pylori genotype with esophagitis and PUD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752979      PMCID: PMC3165571          DOI: 10.1128/JCM.00469-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Recombination and clonal groupings within Helicobacter pylori from different geographical regions.

Authors:  M Achtman; T Azuma; D E Berg; Y Ito; G Morelli; Z J Pan; S Suerbaum; S A Thompson; A van der Ende; L J van Doorn
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

2.  Distribution of vacA and cagA genotypes of Helicobacter pylori in Kuwait.

Authors:  Asmaa Al Qabandi; A S Mustafa; I Siddique; A K Khajah; J P Madda; T A Junaid
Journal:  Acta Trop       Date:  2005-03       Impact factor: 3.112

Review 3.  Clinical outcome of patients with Helicobacter pylori infection: the bug, the host, or the environment?

Authors:  S N Sgouros; C Bergele
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

4.  The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection.

Authors:  John J Carothers; Michael G Bruce; Thomas W Hennessy; Michael Bensler; Julie M Morris; Alisa L Reasonover; Debby A Hurlburt; Alan J Parkinson; John M Coleman; Brian J McMahon
Journal:  Clin Infect Dis       Date:  2006-12-07       Impact factor: 9.079

5.  Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.

Authors:  Y Yamaoka; T Kodama; O Gutierrez; J G Kim; K Kashima; D Y Graham
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.

Authors:  Michael G Bruce; Dana L Bruden; Brian J McMahon; Thomas W Hennessy; Alisa Reasonover; Julie Morris; Debby A Hurlburt; Helen Peters; Frank Sacco; Patrick Martinez; Michael Swenson; Douglas E Berg; Debra Parks; Alan J Parkinson
Journal:  Helicobacter       Date:  2006-12       Impact factor: 5.753

Review 7.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.

Authors:  B J McMahon; M G Bruce; T W Hennessy; D L Bruden; F Sacco; H Peters; D A Hurlburt; J M Morris; A L Reasonover; G Dailide; D E Berg; A J Parkinson
Journal:  Aliment Pharmacol Ther       Date:  2006-04-15       Impact factor: 8.171

9.  A prospective evaluation of 200 upper endoscopies performed in Alaska Native persons.

Authors:  Frank Sacco; Michael G Bruce; Brian J McMahon; Dana Bruden
Journal:  Int J Circumpolar Health       Date:  2007-04       Impact factor: 1.228

10.  Helicobacter pylori infection among non-Native educators in Alaska.

Authors:  Tracey V Lynn; Michael G Bruce; Michael Landen; Michael Beller; Lisa Bulkow; Ben Gold; Alan Parkinson
Journal:  Int J Circumpolar Health       Date:  2007-04       Impact factor: 1.228

View more
  25 in total

1.  Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran.

Authors:  Abbas Yadegar; Ashraf Mohabati Mobarez; Masoud Alebouyeh; Tabassom Mirzaei; Terry Kwok; Mohammad Reza Zali
Journal:  World J Microbiol Biotechnol       Date:  2014-05-23       Impact factor: 3.312

2.  Five year monitoring of considerable changes in tyrosine phosphorylation motifs of Helicobacter pylori cagA gene in Iran.

Authors:  Mohammad Kargar; Sadegh Ghorbani-Dalini; Abbas Doosti; Akram Najafi
Journal:  J Appl Genet       Date:  2014-10-09       Impact factor: 3.240

Review 3.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

4.  Five-year monitoring of considerable changes in tyrosine phosphorylation motifs of the Helicobacter pylori cagA gene in Iran.

Authors:  Mohammad Kargar; Sadegh Ghorbani-Dalini; Abbas Doosti; Akram Najafi
Journal:  J Appl Genet       Date:  2014-04-26       Impact factor: 3.240

5.  Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility.

Authors:  Hanafiah Alfizah; Awang Hamat Rukman; Ahmad Norazah; Razlan Hamizah; Mohamed Ramelah
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

6.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

7.  Association between cagA and vacA genotypes and pathogenesis in a Helicobacter pylori infected population from South-eastern Sweden.

Authors:  Anneli Karlsson; Anna Ryberg; Marjan Nosouhi Dehnoei; Kurt Borch; Hans-Jürg Monstein
Journal:  BMC Microbiol       Date:  2012-07-02       Impact factor: 3.605

8.  Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia.

Authors:  Ousman Secka; Martin Antonio; Douglas E Berg; Mary Tapgun; Christian Bottomley; Vivat Thomas; Robert Walton; Tumani Corrah; Julian E Thomas; Richard A Adegbola
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

9.  Prevalence of Helicobacter pylori vacA, cagA, and iceA Genotypes in Cuban Patients with Upper Gastrointestinal Diseases.

Authors:  Onelkis Feliciano; Oderay Gutierrez; Lidunka Valdés; Trini Fragoso; Ana Maria Calderin; Antonio Eduardo Valdes; Rafael Llanes
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

10.  Prevalence of Helicobacter pylori vacA, cagA and iceA genotypes and correlation with clinical outcome.

Authors:  Guo-Chao Wei; Jing Chen; Ai-Yun Liu; Miao Zhang; Xiao-Jun Liu; Dan Liu; Jun Xu; Bing-Rong Liu; Hong Ling; Hua-Xing Wu; Ya-Ju DU
Journal:  Exp Ther Med       Date:  2012-09-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.